Quetiapine Fumarate Extended-Release 50 Mg Tablets (Xr) Suppliers & Bulk Manufacturers
Available Forms: Extended-Release tablets (XR)
Available Strengths: 50 mg, 150 mg, 200 mg, 300 mg, 400 mg
Reference Brands: US: Seroquel, Seroquel XR®; EU: Seroquel®, Seroquel Prolong®, Quetiapine Teva®
Category: Antipsychotropic Drugs
Quetiapine XR is an atypical antipsychotic that works by modulating dopamine and serotonin receptors in the brain, helping to stabilize mood and reduce psychotic symptoms. It is used for schizophrenia, bipolar disorder, and as an adjunct in major depressive disorder, offering controlled, once-daily dosing for improved symptom management.
Product Description:
Quetiapine Fumarate XR tablets are FDA-approved in the USA for treating schizophrenia, bipolar disorder, and as an adjunct in major depressive disorder (MDD). Classified as an atypical antipsychotic, the drug mandates a Boxed Warning for increased suicidality in young adults and elderly dementia-related psychosis risks. Manufacturers must ensure GMP compliance, controlled labeling, and post-marketing safety reporting. In the EU, quetiapine XR is regulated via EMA or national authorizations, with stringent requirements for Risk Management Plans (RMPs), PSURs, and bioequivalence data. Explore dossier-ready, globally compliant quetiapine XR formulations at Pharmatradz.com.
Quetiapine Fumarate Extended-Release 50 Mg Tablets (Xr) — third party manufacturing & bulk supply
Quetiapine Fumarate Extended-Release 50 Mg Tablets (Xr) is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
What to include when you enquire
- Destination market — determines which manufacturers hold the right site-level approvals
- First order quantity and estimated annual volume
- Whether you need a registration dossier or the product is already registered
- Packaging, labelling and language requirements
- Incoterms and required shelf life
Manufacturers of Quetiapine Fumarate Extended-Release 50 Mg Tablets (Xr) listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.
Request a quote for Quetiapine Fumarate Extended-Release 50... →The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Quetiapine Fumarate is an atypical antipsychotic medication used to treat psychiatric conditions such as schizophrenia, bipolar disorder (mania and depression), and major depressive disorder (as an adjunct therapy). It helps manage symptoms such as hallucinations, delusions, mood swings, and agitation.
Quetiapine Fumarate is the fumarate salt form of Quetiapine, a dibenzothiazepine derivative that works by modulating neurotransmitters in the brain, including serotonin and dopamine, to restore chemical balance and improve mood and thought processes.
It is marketed under trade names such as Seroquel, Ketipinor, Quetapine XR, and other regional generics.
Quetiapine Fumarate is manufactured by various pharmaceutical companies including AstraZeneca (for Seroquel), Teva Pharmaceuticals, Sun Pharma, Cipla, and other generic manufacturers worldwide.
The generic name is Quetiapine Fumarate.
Common brand names include Seroquel, Ketipinor, and Quetapine XR.
It is manufactured globally, including in the USA, Europe, India, and LATAM, by both innovator and generic pharmaceutical companies.
Related Products
Lithium Carbonate
Strength:
150 mg, 300 mg, 600 mg
Form: Tablets
Reference Brands: Lithobid (USA/LATAM), Priadel (EU)
View Details
Phenobarbital Sodium
Strength:
65 mg/mL, 130 mg/mL.
Form: Injection
Reference Brands: Generic formulations marketed under different names
View DetailsQuick Response Guaranteed | Verified Suppliers
